GlycoNet Webinar Series ft. Dr. Chris Phenix & F. Ifthiha Mohideen

When:
August 12, 2020 @ 11:00 am – 12:00 pm
2020-08-12T11:00:00-06:00
2020-08-12T12:00:00-06:00
Cost:
Free
Contact:
Ali Chou

11:00 am – 11:40 am MT:

Chemical tools for studying glucosidase activity in complex biological samples

Dr. Chris Phenix,
Assistant Professor, University of Saskatchewan

Dr. Chris Phenix obtained his Ph.D. from the University of Saskatchewan under the supervision of Dr. David Palmer in the Department of Chemistry. There he studied the biochemical role of an enzyme found in Sinorhizobium meliloti, a bacteria used as a nitrogen inoculants for leguminous crops. He then went on to postdoctoral studies at UBC/TRIUMF under the supervision of Drs. Stephen Withers, Tom Ruth and Michael Adam. There he worked on the radiochemical synthesis of agents to 18F label β-glucosidases using a mechanism-based approach. The intent of such agents is to PET image the in vivo biodistribution and pharmacokinetics of an exogenously administered β-glucosidase, Glucocerebrosidase, the therapeutic enzyme used for direct enzyme replacement therapy of Gaucher disease. Currently he is a scientist at the Thunder Bay Regional Research Institute and Assistant Professor at the Northern Ontario School of Medicine. He is also an adjunct in Chemistry at Lakehead University. His research is focused on developing probes for PET imaging enzymes important for human health including glucosidases involved in Parkinson’s and other diseases.

11:40 am – 12:00 pm MT:

An engineered in vitro enzymatic pathway for the anticancer anthracycline deoxysugars: TDP-L-acosamine and TDP-L-daunosamine

F. Ifthiha Mohideen,
Graduate Student, Concordia University

Ifthiha is a Ph.D. Candidate in the laboratory of Dr. David Kwan at Concordia University. Her doctoral research focuses on the function and engineering of enzymes involved in the glycosylation of natural products. In particular, she is interested in developing a method for assaying glycosyltransferases in a high-throughput fashion and engineering a novel in vitro enzymatic pathway for the anticancer anthracycline deoxysugars. Before joining Concordia, Ifthiha obtained her B.Sc. (Honors) in Plant Biotechnology from the University of Colombo, Sri Lanka in 2014.

Learn more about other webinars and workshops we offer here.
en_USEnglish
fr_CAFrench en_USEnglish